Your browser doesn't support javascript.
loading
Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based study.
Mwanga, Daniel M; Kadengye, Damazo T; Otieno, Peter O; Wekesah, Frederick M; Kipchirchir, Isaac C; Muhua, George O; Kinuthia, Joan W; Kwasa, Thomas; Machuka, Abigael; Mongare, Quincy; Iddi, Samuel; Davis Jones, Gabriel; Sander, Josemir W; Kariuki, Symon M; Sen, Arjune; Newton, Charles R; Asiki, Gershim.
Afiliação
  • Mwanga DM; African Population and Health Research Center, Nairobi, Kenya; Department of Mathematics, University of Nairobi, Nairobi, Kenya; The Centre for Global Epilepsy, University of Oxford, Oxford, UK. Electronic address: dmwanga@aphrc.org.
  • Kadengye DT; African Population and Health Research Center, Nairobi, Kenya; Department of Statistics and Economics, Kabale University, Kabale, Uganda; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Otieno PO; African Population and Health Research Center, Nairobi, Kenya; Department of Public & Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, Netherlands; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Wekesah FM; African Population and Health Research Center, Nairobi, Kenya; Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Kipchirchir IC; Department of Mathematics, University of Nairobi, Nairobi, Kenya.
  • Muhua GO; Department of Mathematics, University of Nairobi, Nairobi, Kenya.
  • Kinuthia JW; African Population and Health Research Center, Nairobi, Kenya; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Kwasa T; Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Machuka A; Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Mongare Q; Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Iddi S; African Population and Health Research Center, Nairobi, Kenya; Department of Statistics and Actuarial Science, University of Ghana, Accra, Ghana; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Davis Jones G; Oxford Epilepsy Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK; The Centre fo
  • Sander JW; Department of Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK; Chalfont Centre for Epilepsy, Buckinghamshire, UK; Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands; Neurology Department, West China Hospital, Sichuan University, Chengdu, Chin
  • Kariuki SM; Department of Psychiatry, University of Oxford, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Public Health, Pwani University, Kilifi, Kenya; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Sen A; Oxford Epilepsy Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
  • Newton CR; Oxford Epilepsy Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Psychiatry, University of Oxford, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; The Centre for Global Epilepsy, University o
  • Asiki G; African Population and Health Research Center, Nairobi, Kenya; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
Lancet Glob Health ; 12(8): e1323-e1330, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38976998
ABSTRACT

BACKGROUND:

WHO estimates that more than 50 million people worldwide have epilepsy and 80% of cases are in low-income and middle-income countries. Most studies in Africa have focused on active convulsive epilepsy in rural areas, but there are few data in urban settings. We aimed to estimate the prevalence and spatial distribution of all epilepsies in two urban informal settlements in Nairobi, Kenya.

METHODS:

We did a two-stage population-based cross-sectional study of residents in a demographic surveillance system covering two informal settlements in Nairobi, Kenya (Korogocho and Viwandani). Stage 1 screened all household members using a validated epilepsy screening questionnaire to detect possible cases. In stage 2, those identified with possible seizures and a proportion of those screening negative were invited to local clinics for clinical and neurological assessments by a neurologist. Seizures were classified following the International League Against Epilepsy recommendations. We adjusted for attrition between the two stages using multiple imputations and for sensitivity by dividing estimates by the sensitivity value of the screening tool. Complementary log-log regression was used to assess prevalence differences by participant socio-demographics.

FINDINGS:

A total of 56 425 individuals were screened during stage 1 (between Sept 17 and Dec 23, 2021) during which 1126 were classified as potential epilepsy cases. A total of 873 were assessed by a neurologist in stage 2 (between April 12 and Aug 6, 2022) during which 528 were confirmed as epilepsy cases. 253 potential cases were not assessed by a neurologist due to attrition. 30 179 (53·5%) of the 56 425 individuals were male and 26 246 (46·5%) were female. The median age was 24 years (IQR 11-35). Attrition-adjusted and sensitivity-adjusted prevalence for all types of epilepsy was 11·9 cases per 1000 people (95% CI 11·0-12·8), convulsive epilepsy was 8·7 cases per 1000 people (8·0-9·6), and non-convulsive epilepsy was 3·2 cases per 1000 people (2·7-3·7). Overall prevalence was highest among separated or divorced individuals at 20·3 cases per 1000 people (95% CI 15·9-24·7), unemployed people at 18·8 cases per 1000 people (16·2-21·4), those with no formal education at 18·5 cases per 1000 people (16·3-20·7), and adolescents aged 13-18 years at 15·2 cases per 1000 people (12·0-18·5). The epilepsy diagnostic gap was 80%.

INTERPRETATION:

Epilepsy is common in urban informal settlements of Nairobi, with large diagnostic gaps. Targeted interventions are needed to increase early epilepsy detection, particularly among vulnerable groups, to enable prompt treatment and prevention of adverse social consequences.

FUNDING:

National Institute for Health Research using Official Development Assistance.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: População Urbana / Epilepsia Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: População Urbana / Epilepsia Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article